Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulax vs BOTOX for Glabellar Wrinkles
NCT05380154Phase 3Completed
- Sponsor
- Hugel
- Start
- May 2017
- Primary completion
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in glabellar lines, sponsored by Hugel. Started May 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT05380154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05380154.